SCHEMBL6189844

SCHEMBL6189844

CC(C)(C)OC(=O)NCCc1ccccc1C(=O)c1cc(Cl)ccc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.48
NQO2 P16083 1/20 0.47
IDO1 P14902 4/20 0.45
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TP53 P04637 1/20 0.43
GLA P06280 1/20 0.43
MAPT P10636 1/20 0.43
XBP1 P17861 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
LMNA P02545 2/20 0.43
TSHR P16473 2/20 0.43
KCNA5 P22460 1/20 0.42
NOS2 P35228 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6187932 0.89 RECQL (0.50) RECQLIDO1ALDH1A1HPGDKDM4E
SCHEMBL6189525 0.83 CA1 (0.45) IDO1ALDH1A1HPGDHTTMEN1
SCHEMBL30313133 0.81 ALDH1A1 (0.55) NQO2IDO1ALDH1A1HPGDHTT
SCHEMBL3658450 0.81 ALDH1A1 (0.55) NQO2IDO1ALDH1A1HPGDHTT
SCHEMBL6192699 0.81 KDM4E (0.47) NQO2IDO1ALDH1A1HPGDHTT
SCHEMBL31250995 0.78 NQO2 (0.56) NQO2IDO1HPGDHTTMEN1
SCHEMBL1231492 0.78 NQO2 (0.56) NQO2IDO1HPGDHTTMEN1
SCHEMBL24086511 0.78 NQO2 (0.53) NQO2IDO1MEN1KMT2ALMNA
SCHEMBL8199082 0.77 NQO2 (0.44) NQO2IDO1MEN1KMT2ALMNA
SCHEMBL6094751 0.77 NQO2 (0.55) NQO2IDO1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979227-B1 4,1-BENZOXAZEPINES, THEIR ANALOGUES, AND THEIR USE AS SOMATOSTATIN AGONISTS TAKEDA PHARMACEUTICAL (JP) 2005-11-16 EP disclosed
US-6352982-B1 TREATING DIABETES, OBESITY, OR INVETERATE DIARRHEA IN A MAMMAL WHICH COMPRISES ADMINISTERING AN EFFECTIVE AMOUNT OF A COMPOUND OF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-03-05 US disclosed